Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 6/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | HTR1B | P28222 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | LSS | P48449 | 1/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | TOP2A | P11388 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14345462 | 0.91 | CHRNB2 (0.44) | HRH3KDM4EHTR1BCYP1A2CYP2D6 | |
| SCHEMBL18081852 | 0.80 | MAPK8 (0.45) | ALDH1A1SMN1; SMN2CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL24798573 | 0.79 | RXRA (0.40) | SMN1; SMN2 | |
| SCHEMBL14345363 | 0.78 | MAPK8 (0.43) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL22837835 | 0.77 | LSS (0.47) | HRH3KDM4EALDH1A1SMN1; SMN2HTR1B | |
| SCHEMBL16002427 | 0.77 | TSHR (0.42) | ALDH1A1CYP1A2CYP2C19MAOACYP2C9 | |
| SCHEMBL30637349 | 0.76 | RXRA (0.40) | MAOA | |
| SCHEMBL14301472 | 0.74 | KDM4E (0.44) | HRH3KDM4EALDH1A1SMN1; SMN2HTR1B | |
| SCHEMBL21910855 | 0.74 | NPSR1 (0.37) | ALDH1A1CYP2C9 | |
| SCHEMBL8154440 | 0.74 | MAPK8 (0.41) | SMN1; SMN2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008022365-A2 | COMPOSITIONS FOR INFLUENCING THE EFFECTS OF ORGANOPHOSPHORUS COMPOUNDS AND USE OF GALANTHAMINE, ITS DERIVATIVES AND ANALOGUES FOR PRODUCING SUCH COMPOSITIONS | SANOCHEMIA LTD. (MT) | 2008-02-28 | — | — | WO | disclosed |